|
|
Volumn 5, Issue 6, 2008, Pages 903-904
|
|
Amorphous pharmaceutical solids: Characterization, stabilization, and development of marketable formulations of poorly soluble drugs with improved oral absorption
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CELLACEFATE;
ETORICOXIB;
ITRACONAZOLE;
NICARDIPINE;
POLYVINYL ACETATE;
PROPRANOLOL;
RITONAVIR;
ROFECOXIB;
VALDECOXIB;
CRYSTAL STRUCTURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SOLUBILITY;
DRUG STABILITY;
EDITORIAL;
FOURIER ANALYSIS;
GLASS TRANSITION TEMPERATURE;
LARGE SCALE PRODUCTION;
LIGHT SCATTERING;
MICROSCOPY;
MOLECULAR INTERACTION;
MOLECULAR STABILITY;
NONHUMAN;
PH;
PRIORITY JOURNAL;
SCIENTIST;
SPRAY DRYING;
SURFACE PROPERTY;
SYNCHROTRON RADIATION;
X RAY DIFFRACTION;
ADMINISTRATION, ORAL;
CHEMISTRY, PHARMACEUTICAL;
PHYSICAL PROCESSES;
PHYSIOLOGICAL PROCESSES;
|
|
EID: 64649088047
PISSN: 15438384
EISSN: 15438392
Source Type: Journal
DOI: 10.1021/mp800203k Document Type: Editorial |
|
Times cited : (59)
|
|
References (0)
|
